Status:

COMPLETED

A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021

Lead Sponsor:

Forest Laboratories

Conditions:

Eosinophilic Esophagitis

Eligibility:

All Genders

12-55 years

Brief Summary

This purpose of this study is the long-term follow-up of glucocorticosteroid-related adverse events and hypothalamic-pituitary-adrenal axis (HPA) suppression in subjects after discontinuation of study...

Eligibility Criteria

Inclusion

  • Subject completed full participation in Study PR-021 (Subjects discontinued prematurely from PR-021 due to HPA axis suppression will be eligible for study PR-022)
  • Written informed consent (parent or legal guardian must sign when applicable) and assent form, if required
  • Willing and able to adhere to all study procedures

Exclusion

  • Subjects already requiring medications or procedures for the treatment of EoE at the time of enrollment into the follow-up study, such as systemic (oral or parenteral) or inhaled corticosteroids, esophageal dilation, Proton Pump Inhibitors (PPIs) and/or dietary restrictions; in the case of subjects already on PPIs and /or dietary restrictions during Study PR-021, only subjects requiring an increase in dosage of PPIs and/or new dietary restrictions because of worsening of symptoms will be excluded
  • Any physical, mental, or social condition, history or concurrent illness or laboratory abnormality that, in the investigator's judgment, might interfere with study procedures or the ability of the subject to adhere to and complete the study
  • Contraindication to esophagogastroduodenoscopy (EGD) or esophageal biopsy or narrowing of the esophagus precluding EGD
  • Female subjects who are pregnant or breastfeeding
  • Participation in a clinical study involving an investigational drug or investigational device

Key Trial Info

Start Date :

January 1 2012

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2013

Estimated Enrollment :

14 Patients enrolled

Trial Details

Trial ID

NCT01498497

Start Date

January 1 2012

End Date

April 1 2013

Last Update

February 9 2017

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Children's Center for Digestive Health

Atlanta, Georgia, United States, 30342

2

Northwestern University School of Medicine

Chicago, Illinois, United States, 60611

3

Riley Hospital for Children

Indianapolis, Indiana, United States, 46202

4

Mayo Clinic

Rochester, Minnesota, United States, 55905